SQ
OTC · SQZB
SQZ Biotechnologies Company
Healthcare · Biotechnology
$0.02
Up+$0.00 (+0.00%)
Updated Sep 13, 2026, 3:15 PM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 707.79K
- P/E ratio
- -0.01
- Dividend yield
- 0.00%
- 52-week range
- $0.02 – $0.05
- Volume
- 139
- Avg. volume
- 5.97K
Price performance
SQZB price history
1M range · 13 trading sessions · Daily adjusted prices
SQZB closed at $0.02 after 13 trading sessions, up 0.00% for the selected period.
- Last close
- $0.02
- Period change
- +0.00%
- Period low
- $0.02
- Period high
- $0.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 139 |
| Sep 10, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 40K |
| Sep 9, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 1.85K |
| Sep 4, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 295 |
| Sep 3, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 1.95K |
| Sep 1, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 2.41K |
| Aug 28, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 1K |
| Aug 27, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 250 |
| Aug 26, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 730 |
| Aug 25, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 3.12K |
| Aug 24, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 1.7K |
| Aug 21, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 550 |
| Aug 20, 2026 | $0.024 | $0.024 | $0.024 | $0.024 | 100 |
Latest SQZB news
The latest Smart Investors Daily articles mentioning SQZB.
Stock researchCompany · Overview
SQZB research
Overview
Company profile and research snapshot.
Company profile
SQZ BIOTECHNOLOGIES CO
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
